Financial Results Approval
The Board of Directors at their meeting held on October 22, 2026 approved the Unaudited Financial Results for the second quarter ended September 30, 2026.
Financial Performance (₹ in Crore)
| Particulars | Quarter ended 30.09.2026 (Unaudited) | Quarter ended 30.06.2026 (Unaudited) | Quarter ended 30.09.2025 (Unaudited) | Year ended 31.03.2026 (Audited) |
| Net Sales | 1,691.6 | 1,590.6 | 1,507.2 | 5,983.6 |
| Net Profit for the period | 341.6 | 343.1 | 327.5 | 1,325.3 |
Dividend Declaration
The Board declared First Interim Dividend of ₹24 per share for Financial Year 2026-27.
Operational Highlights
- Second consecutive quarter of double digit domestic growth
- Q2 Net Profit after tax growth of 5.5%, excluding one-offs
- Partnership with Kaun Banega Crorepati Season 18 featuring Amitabh Bachchan's prime time sign offs to drive nationwide night brushing movement
- Colgate PerioGard portfolio became first in India to receive Indian Society of Periodontology (ISP) Seal of Acceptance
- Set World Record for Largest Multi-Location Oral Screening Programme, reaching 308,106 students across 547 CBSE-affiliated schools in Tamil Nadu and Puducherry within 10 days
- Partnership with Narcotics Control Bureau (NCB), CBSE, and Indian Dental Association (IDA) of Tamil Nadu
Shareholder Information
Special Window for Physical Shares: Opened from February 5, 2026 to February 4, 2027 for re-lodgement of transfer requests of physical shares pertaining to transfer deeds lodged prior to April 1, 2019. Shares re-lodged for transfer shall be issued only in demat form.
Dividend Claims: Shareholders holding physical shares who have not claimed dividends can update KYC details. Process available on company website and RTA's website. Demat shareholders can update KYC through Depository Participants.
IEPF Transfer: 1st Interim Dividend for financial year 2019-20 will be transferred to IEPF on November 24, 2026. Shareholders requested to claim within stipulated timeline.